Guangzhou, China

Kunfeng Liu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Angitia Biopharmaceuticals Guangzhou Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunfeng Liu. Retrieved from https://idiyas.com/inventor/kunfeng-liu-vmel22xp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunfeng Liu: Innovator in Biopharmaceuticals

Introduction

Kunfeng Liu is a prominent inventor based in Guangzhou, China. He is known for his contributions to the field of biopharmaceuticals, particularly in the development of innovative constructs that have significant implications for medical treatments.

Latest Patents

Kunfeng Liu holds a patent titled "ANTI-SCLEROSTIN CONSTRUCTS AND USES THEREOF." This patent represents a significant advancement in the understanding and application of sclerostin-related therapies.

Career Highlights

He is currently employed at Angitia Biopharmaceuticals Guangzhou Limited, where he continues to push the boundaries of biopharmaceutical research. His work focuses on developing new therapeutic strategies that can improve patient outcomes.

Collaborations

Kunfeng Liu collaborates with talented colleagues, including Xiaofeng Liu and Baozhi Yuan, who contribute to the innovative environment at Angitia Biopharmaceuticals.

Conclusion

Kunfeng Liu's work exemplifies the spirit of innovation in the biopharmaceutical industry. His contributions are paving the way for new treatments that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…